What's in Tehran Heart Center's pipeline?

Tehran Heart Center has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Tehran Heart Center's portfolio?

Top competitors by shared drug class: Actavis Inc., Allergan, EMS, Institute of Liver and Biliary Sciences, India, Medical University of Graz.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/tehran-heart-center.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Tehran Heart Center — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tehran Heart Center pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Fludrocortisone Acetate Tablets	Fludrocortisone Acetate Tablets	phase 3	Mineralocorticoid receptor agonist	Mineralocorticoid receptor (MR)	Endocrinology / Cardiovascular
Midodrine Hydrochloride Tablets	Midodrine Hydrochloride Tablets	phase 3	Alpha-1 adrenergic agonist	Alpha-1 adrenergic receptor	Cardiovascular

Therapeutic area mix

Cardiovascular · 1
Endocrinology / Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Actavis Inc. · 1 shared drug class
Allergan · 1 shared drug class
EMS · 1 shared drug class
Institute of Liver and Biliary Sciences, India · 1 shared drug class
Medical University of Graz · 1 shared drug class
Rawalpindi Medical College · 1 shared drug class
University Tunis El Manar · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Tehran Heart Center:

Cite this brief

Drug Landscape (2026). Tehran Heart Center — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/tehran-heart-center. Accessed 2026-05-17.